Sarcomas of Soft Tissue and Bone.
暂无分享,去创建一个
[1] G. Vassal,et al. Tumors in Adolescents and Young Adults , 2016 .
[2] B. Widemann. Reply to: Glucarpidase for the Treatment of Methotrexate‐Induced Renal Dysfunction and Delayed Methotrexate Excretion , 2016, Pediatric blood & cancer.
[3] P. Meyers. Glucarpidase for the Treatment of Methotrexate‐Induced Renal Dysfunction and Delayed Methotrexate Excretion , 2016, Pediatric blood & cancer.
[4] S. Ferrari,et al. An update on chemotherapy for osteosarcoma , 2015, Expert opinion on pharmacotherapy.
[5] K. S. Hall,et al. Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] U. Dirksen,et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] S. Chanock,et al. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite , 2015, Nature Genetics.
[8] P. Hogendoorn,et al. Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes , 2015, International journal of molecular sciences.
[9] U. Dirksen,et al. Local Control in Ewing Sarcoma of the Chest Wall: Results of the EURO-EWING 99 Trial , 2015, Annals of Surgical Oncology.
[10] M. Sydes,et al. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] M. Stevens,et al. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005). , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] S. Donaldson,et al. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group , 2015, Cancer.
[13] R. Randall,et al. Variability in the reported management of pulmonary metastases in osteosarcoma , 2015, Cancer medicine.
[14] J. Blay,et al. Etoposide and carbo‐or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study , 2015, Pediatric blood & cancer.
[15] K. S. Hall,et al. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment† , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] J. Blay,et al. Response to chemotherapy is not related to chromosome instability in synovial sarcoma. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] P. Tsagozis,et al. The Use of Megaprostheses for Reconstruction of Large Skeletal Defects in the Extremities: A Critical Review , 2014, The open orthopaedics journal.
[18] C. Rodríguez-Galindo,et al. Internal hemipelvectomy in the management of pelvic Ewing sarcoma - are outcomes better than with radiation therapy? , 2014, Journal of pediatric surgery.
[19] J. Blay,et al. 1413OZOLEDRONATE DOES NOT REDUCE THE RISK OF TREATMENT FAILURE IN OSTEOSARCOMA: RESULTS OF THE FRENCH MULTICENTRE OS2006 RANDOMISED TRIAL. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] U. Dirksen,et al. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] U. Dirksen,et al. ENCCA WP17-WP7 consensus paper on teenagers and young adults (TYA) with bone sarcomas. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] U. Dirksen,et al. The value of high‐dose chemotherapy in patients with first relapsed Ewing sarcoma , 2014, Pediatric blood & cancer.
[23] H. Chuang,et al. FDG PET/CT of primary bone tumors. , 2014, AJR. American journal of roentgenology.
[24] James R. Anderson,et al. Vincristine, dactinomycin, cyclophosphamide (VAC) versus VAC/V plus irinotecan (VI) for intermediate-risk rhabdomyosarcoma (IRRMS): A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. , 2014 .
[25] J. Blay,et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. , 2014, The Lancet. Oncology.
[26] B. Morland,et al. A phase II window study of irinotecan (CPT‐11) in high risk ewing sarcoma: A Euro‐E.W.I.N.G. study , 2014, Pediatric blood & cancer.
[27] S. Lipshultz,et al. Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.
[28] G. Ottaviani,et al. Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents , 2013, Cancer.
[29] David M. Thomas,et al. Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] P. Casali,et al. Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult , 2013, Current Treatment Options in Oncology.
[31] G. Demetri,et al. Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[32] S. Bielack,et al. Controversies in childhood osteosarcoma. , 2013, Minerva pediatrica.
[33] Olivier Delattre,et al. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] J. Healey,et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] M. Eriksson,et al. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[36] J. Verweij,et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. , 2012, The Lancet. Oncology.
[37] J. Blay,et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial , 2012, The Lancet.
[38] A. Ferrari,et al. The challenge of access to care for soft tissue sarcomas bridging pediatric and adult age: the Italian pediatric oncology view , 2012, Expert review of anticancer therapy.
[39] A. Ferrari,et al. Rhabdomyosarcoma in adolescents , 2012, Cancer.
[40] Andrea Ferrari,et al. Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database , 2011, Pediatric blood & cancer.
[41] H. Gelderblom,et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? , 2011, European journal of cancer.
[42] U. Dirksen,et al. Risk of recurrence and survival after relapse in patients with Ewing sarcoma , 2011, Pediatric blood & cancer.
[43] P. Casali,et al. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[44] W. Winkelmann,et al. The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] L. Mariani,et al. Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups. , 2011, European journal of cancer.
[46] Marc Ladanyi,et al. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. , 2010, The New England journal of medicine.
[47] U. Dirksen,et al. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] C. Antonescu,et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] U. Dirksen,et al. The value of local treatment in patients with primary, disseminated, multifocal Ewing sarcoma (PDMES) , 2010, Cancer.
[50] S. Bielack,et al. The role of radiotherapy in oseosarcoma. , 2009, Cancer treatment and research.
[51] L. Mariani,et al. The symptom interval in children and adolescents with soft tissue sarcomas , 2009, Cancer.
[52] Andrea Ferrari,et al. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005 , 2009, Cancer.
[53] A. Ferrari,et al. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[54] S. Bielack,et al. Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] L. Qin,et al. A Synovial Sarcoma-Specific Preoperative Nomogram Supports a Survival Benefit to Ifosfamide-Based Chemotherapy and Improves Risk Stratification for Patients , 2008, Clinical Cancer Research.
[56] U. Dirksen,et al. Ewing’s Tumors over the Age of 40 – a Retrospective Analysis of 47 Patients Treated According to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99 , 2008, Oncology Research and Treatment.
[57] F. Farrokhyar,et al. A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma , 2008, Cancer.
[58] J. Eary,et al. Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee , 2008, Pediatric blood & cancer.
[59] S. Bielack,et al. Osteosarcoma: the same old drugs or more? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[60] A. Ferrari,et al. Synovial sarcoma of children and adolescents: the prognostic role of axial sites. , 2008, European journal of cancer.
[61] James R. Anderson,et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] Paul A Meyers,et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] L. Mariani,et al. Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma. , 2007, European journal of cancer.
[64] Samuel Singer,et al. Chemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma , 2007, Annals of surgery.
[65] P. Thall,et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] S. Ferrari,et al. Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60 , 2007, Cancer.
[67] M Beth McCarville,et al. Temozolomide and intravenous irinotecan for treatment of advanced Ewing sarcoma , 2007, Pediatric blood & cancer.
[68] H. Jürgens,et al. Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors , 2006, Pediatric blood & cancer.
[69] P. Terrier,et al. Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] Andrea Ferrari,et al. Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] M. Stevens. Treatment for childhood rhabdomyosarcoma: the cost of cure. , 2005, The Lancet. Oncology.
[72] J. Fletcher,et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] M. Semik,et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[74] A. Ferrari,et al. Vinorelbine and low‐dose cyclophosphamide in the treatment of pediatric sarcomas , 2004, Cancer.
[75] Rossella Bertulli,et al. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution , 2004, Cancer.
[76] James R. Anderson,et al. Age is an independent prognostic factor in rhabdomyosarcoma: A report from the soft tissue sarcoma committee of the children's oncology group , 2004, Pediatric blood & cancer.
[77] S. Ferrari,et al. Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[78] P. Navarria,et al. Rhabdomyosarcoma in adults , 2003, Cancer.
[79] W. Winkelmann,et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[80] M. Munsell,et al. Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] M. Link,et al. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] S. Ferrari,et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] Axel Hoos,et al. Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas , 2002, Annals of surgery.
[84] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[85] James R. Anderson,et al. Rhabdomyosarcoma and Undifferentiated Sarcoma in the First Two Decades of Life: A Selective Review of Intergroup Rhabdomyosarcoma Study Group Experience and Rationale for Intergroup Rhabdomyosarcoma Study V , 2001, Journal of pediatric hematology/oncology.
[86] A. Craft,et al. Survival of children with bone sarcoma in Europe since 1978: results from the EUROCARE study. , 2001, European journal of cancer.
[87] M. Stevens,et al. Survival of children with soft-tissue sarcoma in Europe since 1978: results from the EUROCARE study. , 2001, European journal of cancer.
[88] M Bonetti,et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] C. Antonescu,et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] W. Winkelmann,et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.
[91] D. Crowther. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data , 1997, The Lancet.
[92] W. Enneking. A system of staging musculoskeletal neoplasms. , 1986, Clinical orthopaedics and related research.
[93] J. Vilanova. WHO Classification of Soft Tissue Tumors , 2017 .
[94] Silvia Rossi,et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. , 2014, The Lancet. Oncology.
[95] Sydes,et al. MAPIE vs MAP as postoperative chemotherapy in patients with a poor response to preoperative chemotherapy for newly-diagnosed osteosarcoma: results from EURAMOS-1 (Paper 032) , 2014 .
[96] C. Fletcher,et al. WHO classification of tumours of soft tissue and bone , 2013 .
[97] C. Beauchamp. Comparing Children and Adults With Synovial Sarcoma in the Surveillance, Epidemiology, and End Results Program, 1983 to 2005 , 2010 .
[98] S. Bielack,et al. Osteosarcoma lung metastases detection and principles of multimodal therapy. , 2009, Cancer treatment and research.
[99] J. Blay,et al. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[100] C. Beauchamp. Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients , 2009 .
[101] P. Thall,et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[102] M. Link,et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] W. Winkelmann,et al. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. , 2003, International journal of radiation oncology, biology, physics.
[104] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.